Healthcare -
Biotechnology - NASDAQ - US
$ 6.16
-0.324 %
$ 276 M
Market Cap
-11.41
P/E
YMAB - EPS
EPS YMAB - Y-mAbs Therapeutics, Inc.
-0.49
LAST VALUE
38.61%
2 YEAR CAGR
20.05%
5 YEAR CAGR
0.00%
10 YEAR CAGR